Abbott secures FDA approval for MRI-compatibility for the company's EllipseTM ICD
Abbott announced FDA approval for MR-conditional labeling for the Ellipse™ ICD with Tendril MRI pacing lead and Durata and Optisure high voltage leads adds another patient-centric benefit to the device and will help further improve access for patients suffering from abnormally fast heart rhythms. September 22, 2017